A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Kestrel Therapeutics, Inc.
Kestrel Therapeutics, Inc.
Revolution Medicines, Inc.
Seagen Inc.
Eli Lilly and Company
Pfizer
Pfizer
City of Hope Medical Center
Novartis
Chongqing Precision Biotech Co., Ltd
Elicio Therapeutics
Columbia University
UTC Therapeutics Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Corvus Pharmaceuticals, Inc.
Chongqing Precision Biotech Co., Ltd
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Novartis
MacroGenics
Abramson Cancer Center at Penn Medicine
Northwestern University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
Duke University
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Cancer Research UK
Roger Williams Medical Center
National Cancer Institute (NCI)
Case Comprehensive Cancer Center